The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

Share Price Information for Supply@me Cap (SYME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.019
Bid: 0.017
Ask: 0.019
Change: 0.00 (0.00%)
Spread: 0.002 (11.765%)
Open: 0.019
High: 0.019
Low: 0.019
Prev. Close: 0.018
SYME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Appointment of new independent Non-Executive Chair

6 Jun 2022 07:00

RNS Number : 7706N
Supply @ME Capital PLC
06 June 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN

 

6 June 2022

 

Supply@ME Capital plc

(The "Company" or "SYME")

Appointment of new Chair:

Supply@ME appoints Albert Ganyushin as new independent non-executive chairman

 

Supply@ME Capital plc, the fintech business which provides an innovative Platform for use by manufacturing and trading companies to access Inventory Monetisation© solutions enabling their businesses to generate cashflow, is pleased to announce that the Board of Directors proposes to appoint Albert Ganyushin as a director and new independent non-executive chairman with effect from the conclusion of its Annual General Meeting envisaged by the end of June 2022. He will succeed James Coyle, who stepped down from the role in March of this year.

Mr Ganyushin was appointed as an independent adviser (the "Adviser") to the Company, as stated in the RNS of 4 March 2022 when SYME announced the appointment of the Adviser to complete, inter alia, its strategic review. He has subsequently conducted an assessment of the business focussing on the long-term business objectives and its governance requirements. Mr Ganyushin's knowledge, skills and experience identify him as an excellent candidate to lead the business through its next stage of growth. He will provide leadership, support, and strategic guidance during a period of significant change for the business.

His two-decade career comprises a range of increasingly senior investment and capital markets roles across the US, UK, continental Europe and emerging markets. Mr Ganyushin has a wealth of public markets experience including as Head of International Listings at the New York Stock Exchange and Euronext and Investment Banking at Deutsche Bank. Most recently, Mr Ganyushin has worked as Head of Capital Markets at Dr. Peters Group, an alternative investment and asset manager with a track record of investing and managing over US$8bn in real assets across the transportation infrastructure (shipping and aviation) and specialist real estate. Mr Ganyushin holds an MBA from the London Business School.

SYME Chief Executive, Alessandro Zamboni said:

"I am very pleased to welcome Albert to Supply@ME. He will bring a wealth of capital markets and investment experience and will be a valuable asset when it comes to guiding the Company through its next stage. I look forward to working with him."

SYME Chair, Albert Ganyushin said:

"I am delighted to be joining Supply@ME as its new chair. The opportunity that lies ahead of Supply@ME is clear. I'm looking forward to bringing my experience to help shape the next stage of the development of Supply@ME's unique offering."

 

The following information is disclosed in respect of Mr Ganvushin pursuant to the Financial Conduct Authority's Listing Rules:

 

 

Albert Ganyushin holds or has held the following directorships or partnerships in the past five years:

 

Current Directorships or Partnerships

Austen Grove Capital Limited

Westcott Hill Capital Limited

Wotton Hill Capital LLP

 

Past Directorships or Partnerships

Dr. Peters Asset Invest Ltd

Ross Wisconsin AS

 

Mr Ganyushin does not hold any interests in any shares in the Company.

 

Notes

Supply@ME Capital PLC and its operating subsidiaries (together the "Group") provide an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehouse goods waiting to be sold to end-customers or goods/commodities that are part of a typical import/export transaction. SYME announced in August 2021 the launch of a global Inventory Monetisation programme which will be focused on both inventory in transit monetisation and warehouse goods monetisation. This program will be focused on creditworthy companies and not those in distress or otherwise seeking to monetise illiquid inventories. 

Contacts

Alessandro Zamboni, CEO, Supply@ME Capital plc, investors@supplymecapital.com

Paul Vann, Walbrook PR Limited, +44 (0)20 7933 8780; paul.vann@walbrookpr.com

Brian Norris, Cicero/AMO, +44 (0)20 7947 5317; brian.norris@cicero-group.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPUGGQUPPUAQ
Date   Source Headline
13th Aug 20212:00 pmRNSPrice Monitoring Extension
13th Aug 20217:00 amRNSExecutive Board Appointments
12th Aug 20214:40 pmRNSSecond Price Monitoring Extn
12th Aug 20214:36 pmRNSPrice Monitoring Extension
12th Aug 20212:05 pmRNSSecond Price Monitoring Extn
12th Aug 20212:00 pmRNSPrice Monitoring Extension
10th Aug 20217:00 amRNSAppointment of David Bull to the Board
9th Aug 20217:00 amRNSLaunch of Global Inventory Monetisation Fund
30th Jul 20214:00 pmRNSResult of AGM
29th Jul 20214:40 pmRNSSecond Price Monitoring Extn
29th Jul 20214:35 pmRNSPrice Monitoring Extension
28th Jul 202111:01 amRNSIssue of Equity; CLN Restructuring; Notice of TU
22nd Jul 20217:00 amRNSBoard Changes
6th Jul 20217:00 amRNSCompletion of Acquisition & Board Restructuring
5th Jul 20217:00 amRNSNotice of 2020 AGM
29th Jun 20217:00 amRNSCaptive Bank Funding Strategy Update
28th Jun 20217:00 amRNSPublication of 2020 Annual Accounts
16th Jun 20212:49 pmRNSIssue of £5.6million Convertible Loan Notes
4th Jun 20217:00 amRNSUpdate on Publication of 2020 Annual Accounts
26th May 20217:00 amRNSAcquisition Update
30th Apr 20212:41 pmRNSResult of AGM
23rd Apr 20217:00 amRNSFinancial Calendar Update
19th Apr 20217:00 amRNSAcquisition Update
14th Apr 20212:06 pmRNSSecond Price Monitoring Extn
14th Apr 20212:00 pmRNSPrice Monitoring Extension
8th Apr 20217:00 amRNSNotice of 2019 AGM
1st Apr 20219:05 amRNSSecond Price Monitoring Extn
1st Apr 20219:00 amRNSPrice Monitoring Extension
1st Apr 20217:00 amRNSTrading Update
19th Mar 20217:00 amRNSTransaction Update
17th Mar 20217:00 amRNSAcquisition
9th Mar 20213:09 pmRNSRestoration of Listing and Resumption of Dealings
16th Feb 20217:00 amRNSUpdate on Restoration of Listing
4th Feb 20218:00 amRNSUpdate on Relisting
29th Jan 20217:15 amRNSInterim Results for the 6 months to 30 June 2020
28th Jan 20217:00 amRNSStatutory Audited Accounts to 31 December 2019
21st Jan 20217:32 amRNSTemporary Suspension
20th Jan 20217:00 amRNSShariah Compliant Platform officially approved
19th Jan 20217:00 amRNSChange of Accounting Reference Date
11th Jan 20217:00 amRNSNew Co-Operation Agreement
4th Jan 20219:05 amRNSSecond Price Monitoring Extn
4th Jan 20219:00 amRNSPrice Monitoring Extension
31st Dec 202011:06 amRNSSecond Price Monitoring Extn
31st Dec 202011:00 amRNSPrice Monitoring Extension
31st Dec 20207:00 amRNSInventory Funding: Year-End Update
29th Dec 20207:25 amRNSHolding(s) in Company
29th Dec 20207:25 amRNSDirector/PDMR Shareholding
29th Dec 20207:25 amRNSHolding(s) in Company
29th Dec 20207:25 amRNSDirector/PDMR Shareholding
24th Dec 20207:00 amRNSNew Investment in SYME

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.